NTRK2 and Sepsis: Sigma-1 receptor agonists have been previously shown to suppress antitumor immunity in an IL-10–dependent manner (74), and TrkB signaling has been shown to reduce inflammation in a spinal cord injury model (75); thus, it is reasonable to speculate that fluoxetine may be operating through either receptor in our sepsis model.